Proteomics International Laboratories Ltd (ASX: PIQ) Announces Board and Management Transition
Management Transition
Proteomics International Laboratories Ltd (ASX: PIQ) has announced a planned Board and Management transition. Managing Director, Dr Richard Lipscombe, intends to retire in February 2026, marking his 25th anniversary as Founder and Managing Director. The Board has engaged a specialist biotechnology executive search firm to recruit a new CEO with global experience in diagnostics, medical technology, and digital health commercialisation. Dr Lipscombe will remain as Managing Director until his successor is appointed and the transition is complete.
Executive Comments
Chairman Dr James Williams stated, “On behalf of the Board, we thank Richard for his outstanding contribution as Founder and Managing Director over the past 25 years. Under his leadership, Proteomics International has grown into a global leader in precision diagnostics and precision medicine. We also recognise the importance of planned succession on the journey ahead. This transition provides an opportunity to further strengthen the Company’s leadership in support of the commercialisation of our world-class technology.”
Dr Richard Lipscombe commented, “I am deeply proud of all we have accomplished since founding Proteomics International back in 2001. When we started this extraordinary journey precision medicine was a concept, and now our world-leading innovations are helping to make it a reality. It has been an honour to lead this organisation through a period of technological breakthroughs and commercial progress to the cusp of rolling out multiple tests on two continents. My thanks go the exceptional Board, Management and Operational team here at Proteomics International for their dedication, perseverance and support. Equally, I look forward to supporting the next chapter in the Company’s commercialisation strategy and ensuring a smooth transition for the incoming new CEO.”
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
